atractylenolide iii has been researched along with Cerebral Ischemia in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, F; Lin, W | 1 |
| Chen, J; Chen, L; Jia, C; Jiang, S; Kong, J; Kou, J; Tu, W; Wu, J; Wu, Q; Xu, YXZ; Yang, G; Zhou, K | 1 |
2 other study(ies) available for atractylenolide iii and Cerebral Ischemia
| Article | Year |
|---|---|
Anti-apoptosis effects of codonolactone on cerebral ischemia-reperfusion injury.
Topics: Animals; Anti-Inflammatory Agents; Apoptosis; Brain Ischemia; Humans; Lactones; NF-E2-Related Factor 2; Oxidative Stress; Proto-Oncogene Proteins c-akt; Rats; Rats, Sprague-Dawley; Reperfusion Injury; Sesquiterpenes; Superoxide Dismutase; Tumor Necrosis Factor-alpha | 2022 |
Atractylenolide III ameliorates cerebral ischemic injury and neuroinflammation associated with inhibiting JAK2/STAT3/Drp1-dependent mitochondrial fission in microglia.
Topics: Animals; Brain Ischemia; Cytokines; Dynamins; Gene Expression Regulation; Glucose; Inflammation; Interleukin-1beta; Janus Kinase 2; Lactones; Male; Mice; Microglia; Mitochondrial Dynamics; Phosphorylation; Sesquiterpenes; Signal Transduction; STAT3 Transcription Factor; Stroke | 2019 |